Name: Latest research reports of Star Cement Ltd. authored by BOB Capital Markets Ltd. and published by - Trendlyne research reports.
Item: Star Cement Ltd.
Rating: 5
Author: BOB Capital Markets Ltd.

Summary	Date	Stock	Author	LTP	Target	Price at reco (Change since reco%)	Upside(%)	Type	Report	Discuss
	07 Feb 2025	Star Cement	BOB Capital Markets Ltd.	217.16	248.00	212.59 (2.15%)	14.20	Buy	pdf post cache	Broker Report Star Cement (BUY): Challenges behind, geared for next leap; maintain BUY BOB Capital Markets Ltd. Revenues rose ~10%/12% YoY/QoQ in Q3FY25 backed by volume gains though realisations stayed flat pdf Copy Link Share on Share on Share on Share on Alert
	06 Feb 2025	Somany Ceramics	BOB Capital Markets Ltd. Target	475.45	650.00	505.35 (-5.92%)	36.71	Buy	pdf post cache	Broker Report Somany Ceramics (BUY): Good show in a difficult environment BOB Capital Markets Ltd. Operating profit broadly in line in Q3; SOMC EBITDA margin was relatively stable in Q3 due to high GVT sales and Max plant ramp-up pdf Copy Link Share on Share on Share on Share on Alert
	06 Feb 2025	Greenpanel Industries	BOB Capital Markets Ltd. Target	262.56	360.00	376.50 (-30.26%)	Target met	Hold	pdf post cache	Broker Report Greenpanel Industries (HOLD): Dismal Q3 on MDF supply overhang and rising timber prices BOB Capital Markets Ltd. Sharp contraction in GREENP EBITDA (-71% YoY) for ninth straight quarter on supply overhang in MDF industry and high timber prices pdf Copy Link Share on Share on Share on Share on Alert
	05 Feb 2025	Zydus Wellness	BOB Capital Markets Ltd. Target	1943.90	1987.00	1798.90 (8.06%)	Target met	Hold	pdf post cache	Broker Report Zydus Wellness (HOLD): Margin focus over reinvestments BOB Capital Markets Ltd. Q3FY25 sales came in 2% above consensus while EBITDA was 2% lower due to 15bps lower-than-expected margins pdf Copy Link Share on Share on Share on Share on Alert
	05 Feb 2025	Eris Lifesciences	BOB Capital Markets Ltd. Target	1610.70	1418.00	1390.20 (15.86%)	Target met	Buy	pdf post cache	Broker Report Eris Lifesciences (BUY): First player to launch GLP products in India BOB Capital Markets Ltd. Base domestic growth at 12% vs IMP growth of 8% due to new product launches and price increase pdf Copy Link Share on Share on Share on Share on Alert
	04 Feb 2025	Kajaria Ceramics	BOB Capital Markets Ltd. Reco Target	1042.85	1130.00	959.85 (8.65%)	8.36	Buy	pdf post cache	Broker Report Kajaria Ceramics (BUY): Weak Q3; upgrade to BUY on reasonable valuations BOB Capital Markets Ltd. Weak Q3 on sharp margin contraction due to weak demand in the retail market and high overhead costs of new bathware unit pdf Copy Link Share on Share on Share on Share on Alert
	03 Feb 2025	Divi's Laboratories	BOB Capital Markets Ltd. Reco Target	6636.00	6050.00	5884.10 (12.78%)	Target met	Hold	pdf post cache	Broker Report Divis Labs (HOLD): Back to higher growth trajectory BOB Capital Markets Ltd. Q3 sales/EBITDA/PAT were 0.6%/7.5%/22.3% above our estimates. PAT was higher than estimated due to the adoption of the new tax regime pdf Copy Link Share on Share on Share on Share on Alert
	03 Feb 2025	Greenlam Industries	BOB Capital Markets Ltd. Reco Target	276.22	500.00	562.80 (-50.92%)	Target met	Sell	pdf post cache	Broker Report Greenlam Industries (SELL): Dismal Q3; D/G to SELL on weak earnings and rich valuations BOB Capital Markets Ltd. Dismal Q3 on weak performance of laminates segment and slow ramp-up of plywood segment pdf Copy Link Share on Share on Share on Share on Alert
	01 Feb 2025	Sun Pharmaceutical	BOB Capital Markets Ltd. Reco Target	1666.40	2086.00	1742.20 (-4.35%)	25.18	Buy	pdf post cache	Broker Report Sun Pharma (BUY): Strong performance to continue BOB Capital Markets Ltd. Domestic sales grew by 14% in Q3FY25 driven partially by volume/new launches and price hikes. Strong domestic sales growth to continue pdf Copy Link Share on Share on Share on Share on Alert
	01 Feb 2025	IndusInd Bank	BOB Capital Markets Ltd. Target	805.15	1190.00	1009.40 (-20.23%)	47.80	Buy	pdf post cache	Broker Report Indusind Bank (BUY): Missed on most metrics BOB Capital Markets Ltd. Subdued quarter with moderate growth in advances and deposits, MFI book under stress pdf Copy Link Share on Share on Share on Share on Alert
more loading

BOB Capital Markets Ltd. Broker Research reports

Latest broker research reports from BOB Capital Markets Ltd. buy, sell, hold, neutral recommendations along with share price targets forecast and upside.

Star Cement (BUY): Challenges behind, geared for next leap; maintain BUY

Somany Ceramics (BUY): Good show in a difficult environment

Greenpanel Industries (HOLD): Dismal Q3 on MDF supply overhang and rising timber prices

Zydus Wellness (HOLD): Margin focus over reinvestments

Eris Lifesciences (BUY): First player to launch GLP products in India

Kajaria Ceramics (BUY): Weak Q3; upgrade to BUY on reasonable valuations

Divis Labs (HOLD): Back to higher growth trajectory

Greenlam Industries (SELL): Dismal Q3; D/G to SELL on weak earnings and rich valuations

Sun Pharma (BUY): Strong performance to continue

Indusind Bank (BUY): Missed on most metrics

Advisor Screeners